Purpose: To investigate the validity, accuracy, and clinical outcomes of Karyomapping in preimplantation genetic testing (PGT) for β-thalassemia combined with human leukocyte antigen (HLA) matching.
Methods: A total of 128 cycles from January 2014 to December 2017 were identified, and 1205 embryos were biopsied. The case group included 88 cycles using Karyomapping for PGT-HLA, compared with 40 cycles using polymerase chain reaction-short tandem repeat (PCR-STR) as the control group.
Results: There were significant differences in the HLA matching rate (21.34 vs. 14.37%), the matched transferable embryo rate (9.79 vs. 14.07%), the clinical pregnancy rate (65.08 vs. 41.86%), and the spontaneous miscarriage rate (2.44 vs. 22.22%) between the case and control groups. In the case group, nearly 1/3 (33.37%) of the embryos showed aneuploidy. According to the results of single nucleotide polymorphism (SNP) haplotype analysis, the recombination rates of HBB (hemoglobin subunit beta) and HLA were 11.46% and 5.61% respectively. HLA gene recombination was mostly distributed between HLA-A and HLA-B and the downstream region of HLA-DQB1. In addition, STR analysis could be considered in the case of copy-neutral loss of heterozygosity (LOH) in the region where the HLA gene is located.
Conclusion: Karyomapping contributes to accurate selection of matched embryos, along with aneuploidy screening. However, STRs assist identification in cases of LOH in the target region.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911139 | PMC |
| http://dx.doi.org/10.1007/s10815-019-01595-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Preimplantation genetic testing for four families with severe combined immunodeficiency: Three unaffected livebirths.
Orphanet J Rare Dis
January 2025
Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Purpose: Severe combined immunodeficiency (SCID) is a set of rare monogenic inherited diseases that together represent the most severe form of the primary immunodeficiency disease phenotype. Preimplantation genetic testing for monogenic defects (PGT-M) is an effective reproductive technology strategy to prevent disease-causing gene mutations from being transmitted to offspring. The aim of this study was to report the use of PGT-M strategy based on karyomapping in four families to avoid the birth of SCID children.
View Article and Find Full Text PDFHaplotyping-based preimplantation genetic testing for inherited cardiovascular disease: a multidisciplinary approach.
Mol Genet Genomics
December 2024
Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450052, Henan, China.
Given the high morbidity, mortality, and hereditary risk of cardiovascular diseases (CVDs), their prevention and control have garnered widespread attention and remain central to clinical research. This study aims to assess the feasibility and necessity of haplotyping-based preimplantation genetic testing for the prevention of inherited CVD. A total of 15 preimplantation genetic testing for monogenic defect (PGT-M) cycles were performed in 12 CVD families from January 2016 to July 2022.
View Article and Find Full Text PDFA novel approach to detecting microduplication in split hand/foot malformation type 3 at the single-cell level: SHFM as a case study.
Orphanet J Rare Dis
October 2024
The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
Background: Split hand/foot malformation (SHFM) is a congenital limb deficiency characterized by missing or shortened central digits. Several gene loci have been associated with SHFM. Identifying microduplications at the single-cell level is challenging in clinical practice, and traditional detection methods may lead to misdiagnoses in embryos and pregnant women.
View Article and Find Full Text PDFClinical outcomes following preimplantation genetic testing for monogenic conditions: a systematic review of observational studies.
Am J Obstet Gynecol
October 2024
Department of Obstetrics, Gynaecology and Newborn health, University of Melbourne, Parkville, VIC, Australia; Reproductive Epidemiology, Murdoch Children's Research Institute, Parkville, VIC, Australia; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, Australia; The Northern Hospital, Epping, VIC, Australia.
Objective: We aimed to report a summary of clinical outcomes following preimplantation genetic testing for monogenic conditions, by performing a systematic review of published literature on clinical pregnancy and live birth rates following preimplantation genetic testing due to a monogenic indication. Additionally, we aimed to undertake a subgroup analysis of clinical outcomes of concurrent monogenic and aneuploidy screening.
Data Sources: Three electronic databases (MEDLINE, EMBASE, and PubMed) were searched from inception to May 2024.
Successful preimplantation genetic testing for fibrodysplasia ossificans progressiva: a case report.
J Med Case Rep
April 2024
Centre for Reproductive and Genetic Health, 230-232 Great Portland Street, London, W1W 5QS, UK.
Article Synopsis
- Fibrodysplasia ossificans progressiva (FOP) is a rare genetic condition causing disabilities due to abnormal bone formation, with no known effective treatments and an incidence of about 1 in 2 million people.
- A 30-year-old woman with FOP utilized in vitro fertilization (IVF) and preimplantation genetic testing for monogenic disorder (PGT-M) to conceive a healthy baby unaffected by the condition.
- After a complex IVF process involving medication to reduce complications, the couple successfully had a baby through a third embryo transfer, resulting in a healthy birth at 37 weeks, with the child unaffected by FOP.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!